Evidence map›Paper›PMID 26042115›Full record

ArticleFrontiers in microbiology2015

Clicking on trans-translation drug targets.

John N Alumasa, Kenneth C Keiler

Abstract read
In one paragraph

Article in Frontiers in microbiology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. AJournal of bacteriology · 2025
    Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

John N AlumasaDepartment of Biochemistry and Molecular Biology, Pennsylvania State University University Park, PA, USA.
Kenneth C KeilerDepartment of Biochemistry and Molecular Biology, Pennsylvania State University University Park, PA, USA.

Funding

Small Molecule Inhibitors of trans-Translation with Broad Spectrum AntibacterialR43AI113993 · NIAID · MICROBIOTIX, INC · PI ARON, ZACHARY DAVID · 2014 to 2015
$591k
Validation and development of trans-translation as a drug target for MRSAR21AI111692 · NIAID · PENNSYLVANIA STATE UNIVERSITY, THE · PI KEILER, KENNETH C · 2014 to 2015
$425k
NIAID NIH HHS R21 AI111692NIAID NIH HHS R43 AI113993
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

antibacterialchemical biologyclick chemistryfluorescent probemolecular target identificationphoto-affinity labelingtrans-translation

Identifiers

PMID26042115
PMCPMC4436901

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.